00_MJ_Intro_Budapest16.pptx
|
0.MJ_Intro_Budapest16 |
1 |
|
1.VG_Introduction |
24-25 |
|
2.MK_HallmarksCancer_Budapest2016 |
94 |
|
3.MK_CellDeath_Budapest_2016 |
127 |
|
4.BK_cell_surv |
166-167 |
|
5.MJ_Models_Budapest16 |
222 |
|
6.Side Effects KH |
249 |
|
8.MJ_LQapproach_Budapest16 |
274 |
|
9.MK_MolBasisDNAdamageResponse_Budapest_2016 |
301 |
|
12.VG_HFAF |
340-341 |
|
13.MJ_LQpractice_Budapest16 |
428 |
|
13a.MJ_Handout_LQcorrDeriv_Budapest16 |
447 |
|
14.MJ_LETRBE_Budapest16 |
469 |
|
15.BK_OxygenBasic |
497 |
|
16.MK_HypoxiaTumorMicroenvironment_Budapest_2016 |
518 |
|
17.BK_ClinModify hypoxia |
560 |
|
18.MJ_DoseRespRels_Budapest16 |
593 |
|
21.MK_Biological_modifiers_preclinical_Budapest2016 |
623 |
|
22.Biological response modifiers in tumors KH |
662 |
|
23.RC_Biological_modifiers_of_normal_tissue_effects |
689 |
|
24.VG_RT_CH |
722-723 |
|
25.Retreatment tolerance KH |
792 |
|
25a.Cord-retreatment |
814 |
|
26.VG_Funct_Imag |
832-833 |
|
28.RC_Tumor_growth_and_response_to_irradiation |
928 |
|
29.BK_Dose-rate&brachyther |
962-963 |
|
30.VG_Hadron |
1016-1017 |
|
31.MJ_RadnInducedMalig_Budapest16 |
1136 |